Navigation Links
Registration Open for WBBA's Life Science Innovation Northwest 2011 Event Webcast
Date:2/16/2011

SEATTLE, Feb. 16, 2011 /PRNewswire/ -- Register for the webcast now: www.onetotheworld.net/lsinw2011Event: Life Science Innovation Northwest 2011 http://www.washbio.org/displaycommon.cfm?an=1&subarticlenbr=145When: March 2-3, 2011Where: Washington State Convention Center http://www.wsctc.com/Event Detail: http://www.washbio.org/associations/11076/files/LSINW%20Fact%20Sheet%202011.pdfLive Event Registration Information: https://m360.washbio.org/event.aspx?eventID=22551Understand the Webcast Technology: www.onetotheworld.comOne to the World™ (OttW) is pleased to open online registration for the webcast of Life Science Innovation Northwest (LSINW), the region's premier life sciences conference, hosted by the Washington Biotechnology & Biomedical Association (WBBA) and Burrill & Company. Hailing speakers from around the world – this event has never been more global or globally broadcast.

OttW technologists are delivering a dynamic webcast featuring preeminent speakers and LSINW's entire event. LSINW has confirmed prominent Keynote Speakers, James C. Greenwood, President and CEO of the Biotechnology Industry Organization (BIO) in Washington, D.C., and G. Steven Burrill, Founder and CEO of Burrill & Company. OttW's content delivery system enables a far richer visual experience including; high resolution graphics and multiple data streams (video, PowerPoint, Q&A/polling) to run simultaneously. Event programs include:

  1. Partnering to Drive Innovation
  2. Life Sciences in the Pacific Northwest: Creating the Future
  3. Global solutions, Local benefit
  4. Lessons Learned:  How to Position your Company for Success

These preeminent programs highlight the growth and innovation in the Pacific Northwest's life science sector and features medical technology, diagnostics, and therapeutic innovations, as well as cutting-edge scientific and educational developments in global health. Using OttW's polling feature and SuperChat™ viewers can live chat and provide on-the-spot feedback from seats in Seattle and Asia, India, Australia, Scandinavia, and Germany.

Through sponsorship of the live webcast, Global Health Nexus (GHN) http://globalhealthnexus.org/ further cements their leading position of enhancing connection and collaboration between the business and research communities. GHN wealth of expertise and resources support life science innovations throughout the year both regionally and globally.

"At Global Health Nexus we are proud to partner with OttW in delivering this premier broadcast. At OttW we are leading the curve of change in event, training and education communications. It's happening now in the Pacific Northwest - this hub of energy and progress being made in Life Sciences will affect lives throughout the world. This progress belongs to everyone."  ~ John Vadino Founder One to the World™

About One to the World (formerly Dynamic Webcasting) - http://www.onetotheworld.com


'/>"/>
SOURCE One to the World
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Pittsburgh-based BIOSAFE Receives EPA Registration and Enters Into Commercialization Agreement with Union Springs Pharmaceuticals
2. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
3. LS9's UltraClean Diesel™ Receives EPA Registration
4. invivodata Opens Registration for 3rd Annual Patient Reported Outcomes Conference
5. Dempsey Challenge Participant Registration Officially Open
6. 3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)
7. AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma
8. Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
9. Cellu Tissue Holdings, Inc. Files Registration Statement for Proposed Initial Public Offering of Common Stock
10. United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStems Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com
11. PTC Therapeutics Initiates Registration-Directed Phase 3 Trial of Ataluren in Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  Allergan plc (NYSE: ... announced that Brent Saunders , Allergan,s CEO and ... a fireside chat session at the RBC Capital Markets ... p.m. ET at The New York Palace Hotel in ... will be webcast live and can be accessed on ...
(Date:2/10/2016)... ... 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will feature ... in San Francisco’s Moscone Center from February 16-18, 2016, and at the healthcare-focused ... latest InGaAs PIN diode standard packages feature a TO-46 metal can with active areas ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) ... the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies. ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
(Date:1/28/2016)... SAN JOSE, Calif., Jan. 28, 2016 Synaptics (NASDAQ: ... financial results for its second quarter ended December 31, 2015. ... the second quarter of fiscal 2016 increased 2 percent compared to ... the second quarter of fiscal 2016 was $35.0 million, or $0.93 ... Non-GAAP net income for the first quarter of fiscal 2016 ...
Breaking Biology News(10 mins):